In this white paper we provide a fleeting look at some of the CMC ‘building blocks’ that can be assembled for moving a microbiome product from R&D into first into human studies.
All our resources
blog
The European Union has recently introduced a landmark regulation aimed at enhancing the safety, quality, and accessibility of substances of…
webinar
The European Union is transforming its health technology assessment process with the introduction of the Joint Clinical Assessment (JCA) under…
blog
Introduction Bacterial vaginosis (BV) BV is a common vaginal condition characterised by odorous grey vaginal discharge which can be really…
webinar
Microbiome science has grown over the past years with high potential to provide innovative, efficient, and targeted solutions to various…
